Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH Meeting

NEXT STORY
Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting
PREV STORY
Kiadis announces new data at the 2020 ASH Annual Meeting and Exposition
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans

author_avatar
NASDAQ Market News

Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Preliminary Six-Month Data from Open-Label Extension of Phase 2 PaTH Forward Trial and Files IND Amendment to Initiate Phase 3 PaTHway Trial of TransCon™ PTH in Adult Hypoparathyroidism

author_avatar
NASDAQ Market News